Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Chronic spontaneous urticaria

Jane Hsieh and Jason K. Lee
CMAJ January 16, 2017 189 (2) E77; DOI: https://doi.org/10.1503/cmaj.150951
Jane Hsieh
Department of Medicine (Hsieh), Gordon and Leslie Diamond Health Centre, University of British Columbia, Vancouver, BC; Allergy and Clinical Immunology (Lee), University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hsieh.jane@gmail.com
Jason K. Lee
Department of Medicine (Hsieh), Gordon and Leslie Diamond Health Centre, University of British Columbia, Vancouver, BC; Allergy and Clinical Immunology (Lee), University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Chronic spontaneous urticaria is defined by the presence of hives daily or almost daily for at least six weeks

Patients present with recurrent, pruritic, wheal-and-flare lesions that fade within 24 hours without scarring.1 The condition can occur with angioedema in 30%–50% of patients and should be differentiated from acute urticaria (lasting < 6 weeks) and physically induced urticaria (e.g., by cold temperatures or delayed pressure).1

The condition primarily affects the working population and may have a substantial impact on quality of life

Chronic spontaneous urticaria has a peak incidence between the ages of 20 and 40 years, lasting one to five years in most patients, but longer in severe cases.2 The condition affects 0.5%–1% of the general population;2 women are affected twice as often as men.3 School or job performance and sleep can be substantially affected.2

Although the pathophysiology is unknown, autoimmune mechanisms have been proposed

Immunoglobulin E (IgE) autoantibodies have been implicated in the cause of chronic spontaneous urticaria, and autoimmune conditions, such as thyroid disease and systemic lupus erythematosus, have been found to be associated with the condition.3 In contrast to acute urticaria, chronic spontaneous urticaria is not usually caused by IgE-mediated reactions to external allergens (e.g., food).1

The diagnosis is based on a thorough history and physical examination

A recent guideline recommends avoiding extensive testing, because most patients will have no identifiable cause.1 Initial investigations should be limited to a complete blood count with differential, C-reactive protein and erythrocyte sedimentation rate to exclude underlying malignant disease or an inflammatory condition.1

First-line treatment is a second-generation H1-antihistamine

Because the condition is self-limiting, the goal of treatment is symptomatic relief. Second-generation H1-antihistamines are preferred over first-generation antihistamines because they are less sedating and have fewer anticholinergic effects.1,4 For cases refractory to standard doses of H1-antihistamines (up to 50% of cases), treatment can be escalated (Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.150951/-/DC1). Referral to a clinical allergist and immunologist is useful for discussing third-line treatment options.1,2,5

Footnotes

  • See also www.cmaj.ca/lookup/doi/10.1503/cmaj.150154

  • Competing interests: Jason Lee reports receiving grants and personal fees from Novartis AG Canada and Merck Canada. No other competing interests were declared.

  • This article has been peer reviewed.

References

  1. ↵
    1. Zuberbier T,
    2. Aberer W,
    3. Asero R,
    4. et al
    . The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014;69:868–87.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Maurer M,
    2. Weller K,
    3. Bindslev-Jensen C,
    4. et al
    . Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy 2011;66:317–30.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Confino-Cohen R,
    2. Chodick G,
    3. Shalev V,
    4. et al
    . Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol 2012;129:1307–13.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Sharma M,
    2. Bennett C,
    3. Carter B,
    4. et al
    . H1-antihistamines for chronic spontaneous urticaria: an abridged Cochrane Systematic Review. J Am Acad Dermatol 2015;73:710–716.e4.
    OpenUrl
  5. ↵
    1. Kaplan A,
    2. Ledford D,
    3. Ashby M,
    4. et al
    . Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol 2013;132:101–9.
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 189 (2)
CMAJ
Vol. 189, Issue 2
16 Jan 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Chronic spontaneous urticaria
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Chronic spontaneous urticaria
Jane Hsieh, Jason K. Lee
CMAJ Jan 2017, 189 (2) E77; DOI: 10.1503/cmaj.150951

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Chronic spontaneous urticaria
Jane Hsieh, Jason K. Lee
CMAJ Jan 2017, 189 (2) E77; DOI: 10.1503/cmaj.150951
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Chronic spontaneous urticaria is defined by the presence of hives daily or almost daily for at least six weeks
    • The condition primarily affects the working population and may have a substantial impact on quality of life
    • Although the pathophysiology is unknown, autoimmune mechanisms have been proposed
    • The diagnosis is based on a thorough history and physical examination
    • First-line treatment is a second-generation H1-antihistamine
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Azathioprine-induced severe anemia potentiated by the concurrent use of allopurinol
  • Schwannoma of the tongue
  • “Superscan” in diffusion-weighted imaging with background body suppression magnetic resonance imaging
Show more Practice

Similar Articles

Collections

  • Topics
    • Immunology
    • Dermatology
    • Autoimmune disease

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire